1.Strategy to avoid open surgical conversion after endovascular aortic aneurysm repair for patients with infrarenal abdominal aortic aneurysm
Byeoung-Hoon CHUNG ; Seon-Hee HEO ; Yang-Jin PARK ; Dong-Ik KIM ; Duk-Kyoung KIM ; Young-Wook KIM
Annals of Surgical Treatment and Research 2020;99(6):344-351
Purpose:
Open surgical conversion (OSC) is the last treatment option for patients with endovascular aneurysm repair (EVAR) failure. We investigated the underlying causes of EVAR failure requiring OSC and attempted to determine strategies to avoid OSC after EVAR.
Methods:
We retrospectively reviewed the database of patients who underwent OSC after EVAR from 2005 to 2018 in a single institution. Twenty-six OSCs were performed in 24 patients (median age, 74.5 years; 79.2% of males) who had undergone standard EVAR. We investigated pre-, intra-, and postoperative computed tomography or angiographic images and outcomes of the OSCs.
Results:
Two main indications for OSC were persistent endoleak (50.0%) and endograft infection (EI) (38.5%). All 13 patients who underwent OSC due to endoleaks received EVAR outside of indications for use. Among 10 patients who underwent OSC due to EI, we found overlooked infection sources in 7 (70.0%) at the time of EVAR or during the surveillance period.OSC was performed at a median of 31.8 months (interquartile range, 9.4–69.8) after EVAR as an emergency (15.4%) or elective (84.6%) surgery. Aortic endograft was removed in 84.6% of cases (totally, 57.7%; partially, 26.9%), whereas it was preserved in 4 cases (15.4%). After 26 OSCs, 2 early deaths (7.7%) and 2 aortoenteric fistulae (7.7%) developed as major complications.
Conclusion
OSC after EVAR was associated with relatively higher perioperative morbidity and mortality. To avoid OSC after EVAR, we recommend careful assessment of coexisting infection sources and avoidance of EVAR for patients with especially unfavorable anatomy for EVAR, particularly the in proximal neck.
2.Pretreatment Lymph Node Metastasis as a Prognostic Significance inCervical Cancer: Comparison between Disease Status
Soo Young JEONG ; Hyea PARK ; Myeong Seon KIM ; Jun Hyeok KANG ; E Sun PAIK ; Yoo-Young LEE ; Tae Joong KIM ; Jeong Won LEE ; Byoung-Gie KIM ; Duk Soo BAE ; Chel Hun CHOI
Cancer Research and Treatment 2020;52(2):516-523
Purpose:
Lymph node metastasis (LNM) is the most significant prognostic factor in cervical cancerthat was recently incorporated into the International Federation of Gynecology and Obstetrics(FIGO) staging system. This study was performed to evaluate whether the prognosticsignificance of LNM differs according to disease status.
Materials and Methods:
Patients with FIGO stage IB or higher cervical cancer who had pretreatment computedtomography and/or magnetic resonance imaging studies as well as long-term follow-upwere enrolled in this retrospective study. The hazard ratio (HR) of Cox regression was usedto determine the prognostic significance of LNM. The HRs were compared between the differenttumor groups (based on stage, histology, tumor size, primary treatment, age, parametriuminvolvement, and lymphovascular space invasion).
Results:
A total of 970 patients treated between January 1999 and December 2007 were included.The pretreatment LNM had prognostic significance in patients with stage IB1/IIA (HR forprogression-free survival 2.10, p=0.001; HR for overall survival 1.99, p=0.005). However,the significance gradually decreased or disappeared with advancing stages. Similarly, theprognostic significance of the pretreatment LNM decreased with advancing disease status,including old age, parametrial involvement or lymphovascular space involvement. In contrast,the tumor size was associated with the prognostic significance of LNM with advancingstatus. The significance of the clinical LNM did not reflect the significance of the clinicalstage. In contrast, the tumor size, parametrial involvement, and significance of the pathologicLNM reflected the clinical stage.
Conclusion
In patients with cervical cancer, pretreatment LNM on imaging has different clinical significancedepending on the tumor status.
3.Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
Jun Hyeong SEO ; Soo Young JEONG ; Myeong Seon KIM ; Jun Hyeok KANG ; E Sun PAIK ; Yoo Young LEE ; Tae Joong KIM ; Jeong Won LEE ; Byoung Gie KIM ; Duk Soo BAE ; Chel Hun CHOI
Obstetrics & Gynecology Science 2019;62(6):411-419
OBJECTIVE: BRCA mutational status is important in the management of ovarian cancer, but there is a lack of evidence supporting genetic testing in Asian populations. This study was performed to investigate the prevalence and prognostic outcomes of BRCA1/2 mutation and variant of unknown significance (VUS) in Korean patients diagnosed with epithelial ovarian cancer (EOC). METHODS: Among patients newly diagnosed with EOC between January 2007 and January 2017, those tested for germline BRCA1/2 mutation were studied, regardless of family history. Overall survival (OS) and progression-free survival (PFS) were compared between the patients with and without BRCA1/2 mutation and VUS. RESULTS: A total of 313 patients underwent BRCA testing: 88 patients had a BRCA1/2 mutation and 48 patients had a BRCA1/2 VUS (28.1% and 15.3%, respectively). There were no significant associations between BRCA1/2 mutation, BRCA1/2 wild-type, or BRCA1/2 VUS with age at diagnosis, histologic distribution, or residual disease status after primary cytoreductive surgery. BRCA1 mutation, including BRCA1 VUS, showed no difference in PFS or OS compared to BRCA1 wild-type. In contrast, BRCA2 mutation showed longer PFS than that of BRCA2 wild-type (P=0.04) or BRCA2 VUS (P=0.02). BRCA2 mutation, including BRCA2 VUS, did not show any difference in OS compared to BRCA2 wild-type. CONCLUSION: BRCA mutation and BRCA VUS had similar clinical characteristics and survival outcomes, except that BRCA2 mutation showed better PFS. The results of this study will help to understand the prognostic significance of BRCA mutation and VUS in Korean patients.
Asian Continental Ancestry Group
;
Diagnosis
;
Disease-Free Survival
;
Genes, BRCA1
;
Genes, BRCA2
;
Genetic Testing
;
Humans
;
Korea
;
Ovarian Neoplasms
;
Prevalence
4.Age-Specific Cutoff Scores on a T1-Weighted Axial Medial Temporal-Lobe Atrophy Visual Rating Scale in Alzheimer's Disease Using Clinical Research Center for Dementia of South Korea Data.
Gyeong Seon CHOI ; Geon Ha KIM ; Ji Hyun CHOI ; Jihye HWANG ; Eunjin KWON ; Seung Ah LEE ; Kyoung Ae KONG ; Hee Jin KANG ; Bora YOON ; Byeong C. KIM ; Dong Wno YANG ; Duk L. NA ; Eun Joo KIM ; Hae Ri NA ; Hyun Jeong HAN ; Jae Hong LEE ; Jong Hun KIM ; Kang Youn LEE ; Kee Hyung PARK ; Kyung Won PARK ; SangYun KIM ; Seol Heui HAN ; Seong Yoon KIM ; Soo Jin YOON ; So Young MOON ; Young Chul YOUN ; Seong Hye CHOI ; Jee Hyang JEONG
Journal of Clinical Neurology 2018;14(3):275-282
BACKGROUND AND PURPOSE: Visual assessment of medial temporal-lobe atrophy (MTA) has been quick, reliable, and easy to apply in routine clinical practice. However, one of the limitations in visual assessments of MTA is the lack of widely accepted age-adjusted norms and cutoff scores for MTA for a diagnosis of Alzheimer's disease (AD). This study aimed to determine the optimal cutoff score on a T1-weighted axial MTA Visual Rating Scale (VRS) for differentiating patients with AD from cognitively normal elderly people. METHODS: The 3,430 recruited subjects comprising 1,427 with no cognitive impairment (NC) and 2003 AD patients were divided into age ranges of 50–59, 60–69, 70–79, and 80–89 years. Of these, 446 participants (218 in the NC group and 228 in the AD group) were chosen by random sampling for inclusion in this study. Each decade age group included 57 individuals, with the exception of 47 subjects being included in the 80- to 89-year NC group. The scores on the T1-weighted axial MTA VRS were graded by two neurologists. The cutoff values were evaluated from the area under the receiver operating characteristic curve. RESULTS: The optimal axial MTA VRS cutoff score from discriminating AD from NC increased with age: it was ≥as ≥1, ≥2, and ≥3 in subjects aged 50–59, 60–69, 70–79, and 80–89 years, respectively (all p < 0.001). CONCLUSIONS: These results show that the optimal cutoff score on the axial MTA VRS for diagnosing of AD differed according to the decade age group. This information could be of practical usefulness in the clinical setting.
Aged
;
Alzheimer Disease*
;
Atrophy*
;
Cognition Disorders
;
Dementia*
;
Diagnosis
;
Humans
;
Korea*
;
Pemetrexed
;
ROC Curve
5.Electron Microscopy Pathology of ADSSL1 Myopathy.
Hyung Jun PARK ; Jee Eun LEE ; Gyeong Seon CHOI ; Heasoo KOO ; Soo Jeong HAN ; Jeong Hyun YOO ; Young Chul CHOI ; Kee Duk PARK
Journal of Clinical Neurology 2017;13(1):105-106
No abstract available.
Microscopy, Electron*
;
Muscular Diseases*
;
Pathology*
6.Frequency of concomitant ischemic heart disease and risk factor analysis for an early postoperative myocardial infarction after elective abdominal aortic aneurysm repair.
Seung Rim HAN ; Young Wook KIM ; Seon Hee HEO ; Shin Young WOO ; Yang Jin PARK ; Dong Ik KIM ; Jeonghoon YANG ; Seung Hyuk CHOI ; Duk Kyung KIM
Annals of Surgical Treatment and Research 2016;90(3):171-178
PURPOSE: We aimed to see the frequency of concomitant ischemic heart disease (IHD) in Korean patients with abdominal aortic aneurysm (AAA) and to determine risk factors for an early postoperative acute myocardial infarction (PAMI) after elective open or endovascular AAA repair. METHODS: We retrospectively reviewed a database of patients who underwent elective AAA repair over the past 11 years. Patients were classified into 3 groups: control group; group I, medical IHD treatment; group II, invasive IHD treatment. Rates of PAMI and mortality at 30 days were compiled and compared between groups according to the type of AAA repair. RESULTS: Six hundred two elective repairs of infrarenal or juxtarenal AAAs were enrolled in this study. The patients were classified into control group (n = 398, 66.1%), group I (n = 73, 12.1%) and group II (n = 131, 21.8%). PAMI developed more frequently after open surgical repair (OSR) than after endovascular aneurysm repair (EVAR) (5.4% vs. 1.3%, P = 0.012). In OSR patients (n = 373), PAMI developed 2.1% in control group, 18.0% in group I and 7.1% in group II (P < 0.001). In EVAR group (n = 229), PAMI developed 0.6% in control group, 4.3% in group I and 2.2% in group II (P = 0.211). On the multivariable analysis of risk factors of PAMI, PAMI developed more frequently in patients with positive functional stress test. CONCLUSION: The prevalence of concomitant IHD was 34% in Korean AAA patients. The risk of PAMI was significantly higher after OSR compared to EVAR and in patients with IHD compared to control group. Though we found some risk factors for PAMI, these were not applied to postoperative mortality rate.
Aneurysm
;
Aortic Aneurysm, Abdominal*
;
Coronary Artery Disease
;
Exercise Test
;
Humans
;
Mortality
;
Myocardial Infarction*
;
Myocardial Ischemia*
;
Prevalence
;
Retrospective Studies
;
Risk Factors*
7.Practice guidelines for propofol sedation by non-anesthesiologists: the Korean Society of Anesthesiologists Task Force recommendations on propofol sedation.
Hyun KANG ; Duk Kyung KIM ; Yong Seon CHOI ; Young Chul YOO ; Hyun Sik CHUNG
Korean Journal of Anesthesiology 2016;69(6):545-554
In South Korea, as in many other countries, propofol sedation is performed by practitioners across a broad range of specialties in our country. However, this has led to significant variation in propofol sedation practices, as shown in a series of reports by the Korean Society of Anesthesiologists (KSA). This has led the KSA to develop a set of evidence-based practical guidelines for propofol sedation by non-anesthesiologists. Here, we provide a set of recommendations for propofol sedation, with the aim of ensuring patient safety in a variety of clinical settings. The subjects of the guidelines are patients aged ≥ 18 years who were receiving diagnostic or therapeutic procedures under propofol sedation in a variety of hospital classes. The committee developed the guidelines via a de novo method, using key questions created across 10 sub-themes for data collection as well as evidence from the literature. In addition, meta-analyses were performed for three key questions. Recommendations were made based on the available evidence, and graded according to the modified Grading of Recommendations Assessment, Development and Evaluation system. Draft guidelines were scrutinized and discussed by advisory panels, and agreement was achieved via the Delphi consensus process. The guidelines contain 33 recommendations that have been endorsed by the KSA Executive Committee. These guidelines are not a legal standard of care and are not absolute requirements; rather they are recommendations that may be adopted, modified, or rejected according to clinical considerations.
Advisory Committees*
;
Conscious Sedation
;
Consensus
;
Data Collection
;
Deep Sedation
;
Humans
;
Korea
;
Methods
;
Patient Safety
;
Propofol*
;
Standard of Care
8.Efficacy of Feeding Pump for Patients on Enteral Tube Feeding: A Systematic Literature Review and Analysis.
Jin A MO ; Seon Heui LEE ; Mi Hye JEON ; Kyung Sik KIM ; Hwa Soon KIM ; Jae Young JANG ; Myung Duk LEE
The Korean Journal of Gastroenterology 2014;63(2):99-106
BACKGROUND/AIMS: This study was conducted to establish a guideline on the utilizing of feeding pump in patients requiring enteral tube feeding. METHODS: As a first step, textbooks on nutrition and guidelines from regional clinical nutrition societies were analyzed. Afterwards, data on the efficacy, safety, and practicality of feeding pump application were collected and evaluated by systematically reviewing the related literature. As data sources, 8 domestic databases including KoreaMed and global databases such as Ovid-MEDLINE, Ovid-EMBASE, and Cochrane Library were utilized. A total of 2,016 related articles was selected by applying the keyword "(enteral feeding.mp AND pump.mp)". RESULTS: Textbooks and guidelines were not able to draw conclusions on the effects of the feeding pump because the injection speed, tube size, and etcetera were different for enteral feeding. Feeding pump assisted enteral tube feeding was an efficient, safe, and practical procedure for reducing maladjustment-related complications of enteral tube feeding, which are obvious obstacles for maintaining nutritional balances in patients requiring tube feeding. CONCLUSIONS: Feeding pump application can be considered an efficient and safe measure that is acceptable in patients on small intestinal tube feeding, critically-ill patients on gastro-intestinal tube feeding, premature babies, and critically-ill or severely malnourished children (recommendation grade D).
Critical Illness
;
Databases, Factual
;
*Enteral Nutrition
;
Guidelines as Topic
;
Humans
;
Infant, Newborn
;
Intubation, Gastrointestinal
9.A Case of Ascending Colonic Xanthoma Presenting as a Lateral Spreading Tumor.
Sang Hun KIM ; Hyun Soo KIM ; Yoo Duk CHOI ; Won Suk CHOI ; Ban Seok KIM ; Seon Young PARK ; Sung Bum CHO ; Chang Hwan PARK ; Young Eun JOO ; Sung Kyu CHOI ; Jong Sun REW
Intestinal Research 2014;12(2):162-165
Gastrointestinal xanthomas are characterized by foamy cytoplasmic cells containing lipid in lamina propria, and occur almost in the gastric mucosa. Colonic xanthomas have been described in rare case. All reported colonic xanthomas were located in rectosigmoid. Rectosigmoid xanthomas have tended to exhibit small polypoid lesion, on the contrary flat in stomach. We report a case of xanthoma on ascending colon presenting as a laterally spreading tumor resected by endoscopic mucosal resection method.
Colon
;
Colon, Ascending*
;
Cytoplasm
;
Gastric Mucosa
;
Mucous Membrane
;
Polyps
;
Stomach
;
Xanthomatosis*
10.Association of Homocysteine Levels With Blood Lead Levels and Micronutrients in the US General Population.
Yu Mi LEE ; Mi Kyung LEE ; Sang Geun BAE ; Seon Hwa LEE ; Sun Young KIM ; Duk Hee LEE
Journal of Preventive Medicine and Public Health 2012;45(6):387-393
OBJECTIVES: Even though several epidemiological studies have observed positive associations between blood lead levels and homocysteine, no study has examined whether this association differs by the levels of micronutrients, such as folate, vitamin B6, and vitamin B12, which are involved in the metabolism of homocysteine. In this study, we examined the interactions between micronutrients and blood lead on homocysteine levels. METHODS: This study was performed with 4089 adults aged > or =20 years old in the US general population using the National Health and Nutrition Examination Survey 2003-2004. RESULTS: There were significant or marginally significant interactions between micronutrients and blood lead levels on mean homocysteine levels. Positive associations between blood lead and homocysteine were clearly observed among subjects with low levels of folate or low vitamin B6 (p-trend <0.01, respectively). However, in the case of vitamin B12, there was a stronger positive association between blood lead and homocysteine among subjects with high levels of vitamin B12, compared to those with low levels of vitamin B12. In fact, the levels of homocysteine were already high among subjects low in vitamin B12, irrespective of blood lead levels. When we used hyperhomocysteinemia (homocysteine>15 micromol/L) as the outcome, there were similar patterns of interaction, though p-values for each interaction failed to reach statistical significance. CONCLUSIONS: In the current study, the association between blood lead and homocysteine differed based on the levels of folate, vitamin B6, or vitamin B12 present in the blood. It may be important to keep sufficient levels of these micronutrients to prevent the possible harmful effects of lead exposure on homocysteine levels.
Adult
;
Aged
;
Female
;
Folic Acid/blood
;
Homocysteine/*blood
;
Humans
;
Lead/*blood
;
Male
;
Micronutrients/*blood
;
Middle Aged
;
Nutrition Surveys
;
Odds Ratio
;
United States
;
Vitamin B 12/blood
;
Vitamin B 6/blood

Result Analysis
Print
Save
E-mail